Adaptive Biotechnologies vs Alto Neuroscience
Adaptive Biotechnologies vs Alto Neuroscience, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and Alto Neuroscience on 43/100.
Where each one leads
Adaptive Biotechnologies
- our overall score: 69/100 against 43/100
- domain rating: 61/100 against 44/100
Alto Neuroscience
- agent readiness: 48/100 against 39/100
At a glance
| Measure | Adaptive Biotechnologies | Alto Neuroscience |
|---|---|---|
| What it is | Leveraging the adaptive immune system to diagnose and treat disease. | Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions. |
| Category | Biotech, HealthTech, Genomics, Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | services | platform | Platform |
| Founded | 2009 | 2019 |
| Headquarters | Seattle, United States | Los Altos, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Adaptive Biotechnologies | Alto Neuroscience |
|---|---|---|
| Employees | Not published | 86 |
| Total funding | $300M | $370M |
| Latest round | Series D | Registered Direct Offering |
| LinkedIn followers | Not published | 24,482 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptive Biotechnologies | Alto Neuroscience |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 43/100 |
| Traction | Not published | 59/100 |
| Community | Not published | 13/100 |
| Search visibility | Not published | 35/100 |
| Quality | Not published | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (48/100) |
| Domain ratingLink authority, 0-100 | 61/100 | 44/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptive Biotechnologies | Alto Neuroscience |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4 |
Adaptive Biotechnologies vs Alto Neuroscience: common questions
Which is better, Adaptive Biotechnologies or Alto Neuroscience?
On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Adaptive Biotechnologies and Alto Neuroscience compare on the numbers?
Adaptive Biotechnologies leads on our overall score (69/100 against 43/100), domain rating (61/100 against 44/100). Alto Neuroscience leads on agent readiness (48/100 against 39/100).
Read the full Adaptive Biotechnologies review and pricing or the Alto Neuroscience review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.